The results of Western blotting showed that NaBu treatment for 48 h suppressed the expressions of HK2, PFK1 and LDH‐A in the HCC‐LM3 and Bel‐6402 cell lines in a dose‐dependent manner (Figure 2E). The gene discussed is PFKM; the disease is hepatocellular carcinoma.